Mimedx (MDXG) Receivables (2010 - 2026)

Mimedx has disclosed Receivables across 17 years of filings, most recently posting $55.6 million for Q1 2026.

• Receivables for Q1 2026 came in at $55.6 million, down 10.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $55.6 million (down 10.78% YoY), and the FY2025 annual result was $84.4 million, up 43.16% from the prior year.
• Receivables came in at $55.6 million for Q1 2026 at Mimedx, down from $84.4 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $84.4 million in Q4 2025 to a low of $37.7 million in Q2 2022.
• The 5-year median for Receivables is $53.9 million (2023), against an average of $55.1 million.
• Across the five-year window, Receivables soared 44.71% in 2025 and dropped 10.78% in 2026, its largest moves.
• Mimedx's Receivables stood at $46.9 million in 2022, then grew by 14.94% to $53.9 million in 2023, then grew by 9.45% to $59.0 million in 2024, then surged by 43.16% to $84.4 million in 2025, then sank by 34.16% to $55.6 million in 2026.
• The last three Receivables figures came in at $55.6 million (Q1 2026), $84.4 million (Q4 2025), and $78.2 million (Q3 2025), per Business Quant data.